[ad_1]
Walgreens introduced it’s partnering with Pearl Health, which affords a expertise platform for major care practices in value-based care preparations, to increase value-based care choices in collaboration with major care suppliers.
Pearl Well being affords a expertise platform for major care suppliers collaborating in Medicare’s ACO REACH mannequin. The platform contains information visualizations and proposals that permit clinicians to see which sufferers may have additional help, resembling these with a number of persistent circumstances or these lately discharged from a hospital.
The startup’s instruments intention to distill affected person data into easy-to-digest reviews and monitor metrics like readmission charges and whether or not sufferers attend annual wellness visits.
By the partnership, Walgreens will present complementary prescription success, immunizations, medicine adherence, diagnostic testing and care-gap closure. The pharmacy chain can even work with healthcare suppliers to help sufferers discharged from the hospital transition to residence.
“At Pearl Well being, we consider that native major care suppliers are key to enhancing America’s total well being. Our technology-powered value-based care mannequin aligns seamlessly with the healthcare providers Walgreens affords, significantly in probably the most weak communities,” Michael Kopko, chief government officer of Pearl Well being, stated in a press release.
“With a concentrate on proactive, coordinated care, we’ll collaborate to ship a greater answer to suppliers and finally ship high-quality providers to sufferers whereas managing their care effectively. We’re very excited concerning the implications of this partnership for sufferers in Medicare and past.”
THE LARGER TREND
In January, Pearl Well being raised $75 million in Series B funding. The corporate introduced an $18 million Series A in September 2021.
Different firms offering help and expertise providers to practices in value-based care preparations embrace UpStream Healthcare, which raised $140 million in Series B funding, and Aledade, which scooped up $123 million in a Series E round final 12 months.
[ad_2]
